Tricuspid Valve Insufficiency clinical trials at UCSF
2 research studies open to eligible people
Tricuspid valve insufficiency means the tricuspid valve in the heart doesn't close properly. UCSF is testing a new device to repair the valve and another to replace it. These studies aim to check if these treatments are safe and effective for patients.
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
San Francisco, California and other locations
TRISCEND II Pivotal Trial
open to eligible people ages 18 years and up
Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
San Francisco, California and other locations
Our lead scientists for Tricuspid Valve Insufficiency research studies include Sammy Elmariah, MD.
Last updated: